Twenty Patients Implanted in Functional Neuromodulation, Ltd.'s ADvance Study of Deep Brain Stimulation for Alzheimer's Disease

Published: Jun 12, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

TORONTO--(BUSINESS WIRE)--Functional Neuromodulation Ltd.’s ADvance Study has implanted 20 mild Alzheimer’s patients with deep brain stimulation (DBS) systems, and the U.S. Food and Drug Administration has approved expansion of the study from 20 to 30 U.S. patients in combination with 20 subjects approved in Canada. The U.S. National Institutes of Health is providing support for the trial. The National Institute on Aging, part of NIH, awarded a grant to Dr. Constantine Lyketsos, of Johns Hopkins Bayview Medical Center, Baltimore, and Dr. Andres Lozano, of the University of Toronto. The NIA/NIH grant is expected to total more than $2 million over the next five years.

Help employers find you! Check out all the jobs and post your resume.

Back to news